Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Gene | PALB2 |
Variant | K142Nfs*35 |
Impact List | frameshift |
Protein Effect | loss of function - predicted |
Gene Variant Descriptions | PALB2 K142Nfs*35 indicates a shift in the reading frame starting at amino acid 142 and terminating 35 residues downstream causing a premature truncation of the 1186 amino acid Palb2 protein (UniProt.org). K142Nfs*35 has not been characterized however, due to the effects of other truncation mutations downstream of K142 (PMID: 31636395, PMID: 31757951), is predicted to lead to a loss of Palb2 protein function. |
Associated Drug Resistance | |
Category Variants Paths |
PALB2 mutant PALB2 inact mut PALB2 K142Nfs*35 |
Transcript | NM_024675.4 |
gDNA | chr16:g.23636120delC |
cDNA | c.426delG |
Protein | p.K142Nfs*35 |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
XM_011545946.2 | chr16:g.23636127_23636128insGGGGGGGGGGGGGGGGGGTTGT | c.425_426insCAACCCCCCCCCCCCCCCCCCA | p.K142Nfs*35 | RefSeq | GRCh38/hg38 |
XM_017023672.2 | chr16:g.23636120delC | c.426delG | p.K142Nfs*35 | RefSeq | GRCh38/hg38 |
XM_017023673.2 | chr16:g.23636120delC | c.426delG | p.K142Nfs*35 | RefSeq | GRCh38/hg38 |
NM_001407298.1 | chr16:g.23636120delC | c.426delG | p.K142Nfs*35 | RefSeq | GRCh38/hg38 |
NM_001407310.1 | chr16:g.(23635130_23635237) | c.(424_531) | p.K142Nfs*35 | RefSeq | GRCh38/hg38 |
NM_001407307.1 | chr16:g.(23635130_23635237) | c.(424_531) | p.K142Nfs*35 | RefSeq | GRCh38/hg38 |
NM_001407300.1 | chr16:g.23636120delC | c.426delG | p.K142Nfs*35 | RefSeq | GRCh38/hg38 |
NM_001407299.1 | chr16:g.23636120delC | c.426delG | p.K142Nfs*35 | RefSeq | GRCh38/hg38 |
NM_024675.4 | chr16:g.23636120delC | c.426delG | p.K142Nfs*35 | RefSeq | GRCh38/hg38 |
NM_001407311.1 | chr16:g.(23635130_23635237) | c.(424_531) | p.K142Nfs*35 | RefSeq | GRCh38/hg38 |
XM_017023671.1 | chr16:g.23636127_23636128insGGGGGGGGGGGGGGGGGGTTGT | c.425_426insCAACCCCCCCCCCCCCCCCCCA | p.K142Nfs*35 | RefSeq | GRCh38/hg38 |
NM_001407306.1 | chr16:g.(23635130_23635237) | c.(424_531) | p.K142Nfs*35 | RefSeq | GRCh38/hg38 |
NM_001407297.1 | chr16:g.23636120delC | c.426delG | p.K142Nfs*35 | RefSeq | GRCh38/hg38 |
NM_001407302.1 | chr16:g.23636120delC | c.426delG | p.K142Nfs*35 | RefSeq | GRCh38/hg38 |
NM_001407308.1 | chr16:g.(23635130_23635237) | c.(424_531) | p.K142Nfs*35 | RefSeq | GRCh38/hg38 |
NM_001407301.1 | chr16:g.23636120delC | c.426delG | p.K142Nfs*35 | RefSeq | GRCh38/hg38 |
NM_001407309.1 | chr16:g.(23635130_23635237) | c.(424_531) | p.K142Nfs*35 | RefSeq | GRCh38/hg38 |
XM_011545947.2 | chr16:g.23636127_23636128insGGGGGGGGGGGGGGGGGGTTGT | c.425_426insCAACCCCCCCCCCCCCCCCCCA | p.K142Nfs*35 | RefSeq | GRCh38/hg38 |
NM_024675.3 | chr16:g.23636120delC | c.426delG | p.K142Nfs*35 | RefSeq | GRCh38/hg38 |
NM_001407305.1 | chr16:g.(23635130_23635237) | c.(424_531) | p.K142Nfs*35 | RefSeq | GRCh38/hg38 |
XM_011545948.2 | chr16:g.(23635130_23635237) | c.(424_531) | p.K142Nfs*35 | RefSeq | GRCh38/hg38 |
NM_001407304.1 | chr16:g.(23635130_23635237) | c.(424_531) | p.K142Nfs*35 | RefSeq | GRCh38/hg38 |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|